Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.8900-0.0574 (-6.06%)
At close: 03:59PM EST
0.8799 -0.01 (-1.13%)
After hours: 08:00PM EST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
19,975
10,884
4,101
749
Cost of Revenue
8,440
6,836
10,718
282
Gross Profit
11,535
4,048
-6,617
467
Operating Expenses
Research Development
2,523
3,253
6,246
13,500
Selling General and Administrative
31,722
42,229
58,142
36,020
Total Operating Expenses
34,245
45,482
64,388
49,520
Operating Income or Loss
-22,710
-41,434
-71,005
-49,053
Interest Expense
1,546
3,131
3,914
3,109
Total Other Income/Expenses Net
10,239
14,398
3,827
-
Income Before Tax
-13,926
-30,087
-71,067
-51,853
Income Tax Expense
0
-4,675
0
0
Income from Continuing Operations
-13,926
-25,412
-71,067
-51,853
Net Income
-13,926
-25,412
-71,067
-51,853
Net Income available to common shareholders
-13,926
-25,412
-71,067
-51,853
Basic EPS
7.31
-59.00
-1.54k
-1.22k
Diluted EPS
7.31
-59.00
-1.54k
-1.22k
Basic Average Shares
1,621
432.218
48.536
42.341
Diluted Average Shares
1,621
432.218
48.536
42.341